ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 64 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 3.29 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $62,000 | -89.9% | 10,272 | -87.4% | 0.00% | -90.3% |
| Q3 2019 | $615,000 | +515.0% | 81,372 | +342.5% | 0.03% | +416.7% |
| Q1 2019 | $100,000 | +222.6% | 18,388 | +73.7% | 0.01% | +200.0% |
| Q4 2018 | $31,000 | -91.2% | 10,586 | -75.6% | 0.00% | -87.5% |
| Q3 2018 | $353,000 | +113.9% | 43,360 | +155.6% | 0.02% | +128.6% |
| Q2 2018 | $165,000 | -78.1% | 16,961 | -80.5% | 0.01% | -76.7% |
| Q1 2018 | $754,000 | -7.3% | 86,877 | +33.7% | 0.03% | -16.7% |
| Q4 2017 | $813,000 | -27.5% | 64,998 | -51.5% | 0.04% | -36.8% |
| Q3 2017 | $1,121,000 | – | 134,123 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 507,191 | $5,107,000 | 0.50% |
| Cormorant Asset Management, LP | 356,600 | $3,591,000 | 0.43% |
| Perceptive Advisors | 558,446 | $5,623,000 | 0.42% |
| NEXTHERA CAPITAL LP | 15,000 | $151,000 | 0.21% |
| EMERALD ADVISERS, LLC | 237,070 | $2,387,000 | 0.11% |
| AUXIER ASSET MANAGEMENT | 17,857 | $180,000 | 0.04% |
| FEDERATED HERMES, INC. | 450,000 | $4,532,000 | 0.01% |
| Nationwide Fund Advisors | 49,473 | $498,000 | 0.00% |
| Catalyst Capital Advisors LLC | 348 | $4,000 | 0.00% |
| DEUTSCHE BANK AG\ | 859 | $8,000 | 0.00% |